Section Arrow
MYGN.NASDAQ
- Myriad Genetics
Quotes are at least 15-min delayed:2024/09/28 16:00 EDT
Last
 26.46
+0.23 (+0.88%)
Day High 
26.95 
Prev. Close
26.23 
1-M High
29.3 
Volume 
564.35K 
Bid
25.5
Ask
30
Day Low
26.215 
Open
26.4 
1-M Low
24.74 
Market Cap 
2.38B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 27.43 
20-SMA 27.26 
50-SMA 27.42 
52-W High 29.3 
52-W Low 13.82 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.77/0.06
Enterprise Value
2.52B
Balance Sheet
Book Value Per Share
8.15
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
753.20M
Operating Revenue Per Share
8.09
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ME23andMe Holding Co0.2941-0.0241-7.57%-- 
OPKOPKO Health1.52+0.03+2.01%-- 
MYNZMainz Biomed NV0.247+0.0331+15.47%-- 
AAgilent Technologies148.06+1.32+0.90%30.51PE
QGENQiagen NV45.24+0.22+0.49%130.2PE
Quotes are at least 15-min delayed:2024/09/28 16:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarkerdiscovery and companion diagnostic services to pharma and biotech companies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.